Your browser doesn't support javascript.
loading
Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect.
Valcz, Gábor; Patai, Arpád V; Kalmár, Alexandra; Péterfia, Bálint; Furi, István; Wichmann, Barnabás; Muzes, Györgyi; Sipos, Ferenc; Krenács, Tibor; Mihály, Emese; Spisák, Sándor; Molnár, Béla; Tulassay, Zsolt.
Afiliação
  • Valcz G; Molecular Medicine Research Unit, Hungarian Academy of Sciences, Budapest, Hungary.
  • Patai AV; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Kalmár A; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Péterfia B; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Furi I; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Wichmann B; Molecular Medicine Research Unit, Hungarian Academy of Sciences, Budapest, Hungary.
  • Muzes G; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Sipos F; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Krenács T; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Mihály E; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Spisák S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Molnár B; Molecular Medicine Research Unit, Hungarian Academy of Sciences, Budapest, Hungary; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Tulassay Z; Molecular Medicine Research Unit, Hungarian Academy of Sciences, Budapest, Hungary; 2nd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
PLoS One ; 9(11): e106143, 2014.
Article em En | MEDLINE | ID: mdl-25405986
ABSTRACT
Epigenetic changes of stromal-epithelial interactions are of key importance in the regulation of colorectal carcinoma (CRC) cells and morphologically normal, but genetically and epigenetically altered epithelium in normal adjacent tumor (NAT) areas. Here we demonstrated retained protein expression of well-known Wnt inhibitor, secreted frizzled-related protein 1 (SFRP1) in stromal myofibroblasts and decreasing epithelial expression from NAT tissues towards the tumor. SFRP1 was unmethylated in laser microdissected myofibroblasts and partially hypermethylated in epithelial cells in these areas. In contrast, we found epigenetically silenced myofibroblast-derived SFRP1 in CRC stroma. Our results suggest that the myofibroblast-derived SFRP1 protein might be a paracrine inhibitor of epithelial proliferation in NAT areas and loss of this signal may support tumor proliferation in CRC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Colorretais / Peptídeos e Proteínas de Sinalização Intercelular / Miofibroblastos / Proteínas de Membrana Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Hungria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Colorretais / Peptídeos e Proteínas de Sinalização Intercelular / Miofibroblastos / Proteínas de Membrana Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Hungria